Correlated downregulation of VDR and CYP3A4 in colorectal cancer

Hossein Sadeghi1, Veys Hashemnia2, Ehsan Nazemalhosseini-Mojarad3

  • 1Genomic Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Molecular Biology Reports
|December 5, 2022
PubMed
Abstract

Insights

Vitamin D receptor (VDR) and CYP3A4 gene expression are significantly reduced in colorectal cancer (CRC). This downregulation may impair vitamin D metabolism and contribute to CRC development, suggesting diagnostic potential.

Area of Science:

  • Molecular biology
  • Cancer research
  • Endocrinology

Background:

  • Vitamin D exhibits tumor-suppressive properties by regulating cell differentiation, proliferation, and apoptosis.
  • Aberrant expression of vitamin D metabolism genes is implicated in various cancers.

Purpose of the Study:

  • To investigate the expression levels of vitamin D metabolic pathway genes (VDR, CYP3A4, RXRα, GC) in colorectal cancer (CRC) tissues versus adjacent normal tissues.
  • To assess the diagnostic potential of these genes in CRC.

Main Methods:

  • Quantitative reverse transcription polymerase chain reaction (RT-PCR) was employed to measure gene expression.
  • Comparison of gene expression between CRC samples and adjacent non-cancerous tissues.
  • Receiver Operating Characteristic (ROC) curve analysis was performed.

Main Results:

  • Significant downregulation of CYP3A4 and VDR gene expression was observed in CRC tissues compared to adjacent tissues (p < 0.01).
  • No significant alteration in RXRA and GC expression levels was found.
  • A strong positive correlation between CYP3A4 and VDR expression (p < 0.0001) and diagnostic potential for CYP3A4 and VDR were identified.

Conclusions:

  • Reduced expression of CYP3A4 and VDR is linked to colorectal cancer, potentially through impaired vitamin D metabolism.
  • Further research is warranted to explore the role of these genes in CRC pathogenesis and therapeutic strategies.